Last reviewed · How we verify

NCT05308823

Outcome of Cerebral Venous Sinuses Stenting on Idiopathic Intracranial Hypertension

Status unknown NA Last updated 4 April 2022
What this trial tests

NA trial testing Stent in Idiopathic Intracranial Hypertension in 20 participants. Status unknown.

Timeline
15 March 2022
Primary endpoint
15 July 2022
5 September 2022

Quick facts

Lead sponsorAl-Azhar University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment20
Start date15 March 2022
Primary completion15 July 2022
Estimated completion5 September 2022
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Al-Azhar University

Who can join

18 and older, any sex, with Idiopathic Intracranial Hypertension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the work is to asses the positive effect of stenotic sinus segment stenting on idiopathic intracranial hypertension with headache and papilloedema.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Stent

Trials testing the same drug.

Other recruiting trials for Idiopathic Intracranial Hypertension

Currently open trials in the same condition.

Other Al-Azhar University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05308823.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing